Bibliography
Found 15 results
Filters: Author is Achim, Cristian L [Clear All Filters]
Accelerated epigenetic aging in brain is associated with pre-mortem HIV-associated neurocognitive disorders. J Neurovirol. 2016 ;22(3):366-75.
. Alterations in brain TREM2 and Amyloid-β levels are associated with neurocognitive impairment in HIV-infected persons on antiretroviral therapy. J Neurochem. 2018 .
Alzheimer-type cerebral amyloidosis in the context of HIV infection: implications for a proposed new treatment approach. Res Sq. 2023 .
. Antiretroviral therapy reduces neurodegeneration in HIV infection. AIDS. 2015 ;29(3):323-30.
. Beta amyloid levels in cerebrospinal fluid of HIV-infected people vary by exposure to antiretroviral therapy. AIDS. 2020 ;34(7):1001-1007.
. Can research at the end of life be a useful tool to advance HIV cure?. AIDS. 2017 ;31(1):1-4.
. CSF markers of AD-related pathology relate specifically to memory impairment in older people with HIV: a pilot study. J Neurovirol. 2022 ;28(1):162-167.
. . Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons. J Neuropsychiatry Clin Neurosci. 2011 ;23(3):316-23.
HIV protease inhibitor exposure predicts cerebral small vessel disease. AIDS. 2014 ;28(9):1297-306.
Lifetime methamphetamine dependence is associated with cerebral microgliosis in HIV-1-infected adults. J Neurovirol. 2016 ;22(5):650-660.
. Mitochondrial biogenesis is altered in HIV+ brains exposed to ART: Implications for therapeutic targeting of astroglia. Neurobiol Dis. 2019 ;130:104502.
Mitochondrial injury and cognitive function in HIV infection and methamphetamine use. AIDS. 2016 ;30(6):839-48.
. Multilevel analysis of neuropathogenesis of neurocognitive impairment in HIV. J Neurovirol. 2016 ;22(4):431-41.
.